The cost of Eliquis can vary significantly based on several factors, including insurance coverage, pharmacy, and whether a discount program is used.
How to Find Lower Eliquis Prices
Patients looking for more affordable Eliquis may find savings through prescription discount cards or coupons. These programs can often reduce the out-of-pocket cost, especially for those without comprehensive insurance coverage. Online pharmacies and comparing prices across different brick-and-mortar locations can also reveal cost differences.
Eliquis Pricing and Insurance
Insurance plans typically have a formulary that dictates which medications are covered and at what tier. Eliquis, like other brand-name drugs, may have a higher co-pay or deductible compared to generic alternatives if they were available. Prescription assistance programs offered by the manufacturer or third-party organizations can help eligible patients manage medication costs.
Eliquis Patent and Generic Availability
Eliquis (apixaban) is protected by patents, which generally prevent generic versions from entering the market until those patents expire. Patent expiration dates are crucial for understanding when lower-cost generic options might become available. Information on drug patents and their expiration timelines can be found on resources like DrugPatentWatch.com [1]. As of now, generic Eliquis is not widely available.
Factors Affecting Eliquis Cost
The price of Eliquis is influenced by its status as a brand-name drug, the complexity of its manufacturing, and market demand. Pharmacy benefit managers and insurance companies negotiate prices, which can lead to variations in what patients pay. Furthermore, the dosage and quantity of Eliquis prescribed will also impact the overall cost.
Manufacturer Discounts and Assistance Programs
Bristol Myers Squibb, a co-developer of Eliquis, offers savings programs for eligible patients. These programs can significantly lower the cost for those who qualify, providing a pathway to more affordable access to the medication. Details on these programs are typically available through the drug manufacturer's website or by speaking with a healthcare provider.
Sources:
[1] DrugPatentWatch.com